Upload Records Snowball Search Search OpenAlex
About the database ScholarIQanswers from OpenAlex & ORCID
How has Zhikang Chen's publication output changed over time?
ScholarIQpublication output · 2008–2023
Output grew0% over the shown period — from 1 works in 2008 to 1 in 2023.
1
1
1
2
1
2
2
1
20082009201020112018201920212023
What are the most-cited papers on Zhikang Chen?
ScholarIQmost cited works
LncRNA HOTAIR is a Prognostic Biomarker for the Proliferation and Chemoresistance of Colorectal Cancer via MiR-203a-3p-Mediated Wnt/ß-Catenin Signaling Pathway
Zhigang Xiao, Zhan Qu, Zhikang Chen, Zhixue Fang, Ke Zhou, Zhongcheng Huang, Xiong Guo, Yang Zhang
S161399637. 2018150 CitationsOPEN ACCESS
Targeting Tumor Microenvironment by Small-Molecule Inhibitors
Shangwei Zhong, Ji-Hak Jeong, Zhikang Chen, Zihua Chen, Jun‐Li Luo
S106638657. 2019139 CitationsOPEN ACCESS
Overexpression of G6PD is associated with poor clinical outcome in gastric cancer
Jixu Wang, Weijie Yuan, Zhikang Chen, Zhikang Chen, Shaobin Wu, Jinxiang Chen, Jie Ge, Futao Hou, Zihua Chen, Zihua Chen
S12644804. 2011131 Citations
EphA2–YES1–ANXA2 pathway promotes gastric cancer progression and metastasis
Linfeng Mao, Weijie Yuan, Kaimei Cai, Chen Lai, Changhao Huang, Yi Xu, Shangwei Zhong, Yang Chen, Ran Wang, Pengwei Zeng, Heyuan Huang, Zhikang Chen, Zihua Chen, Zihua Chen, Zihua Chen
S128439998. 202187 CitationsOPEN ACCESS
EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance
Changhao Huang, Weijie Yuan, Lai Chen, Shangwei Zhong, Yang Chen, Ran Wang, Linfeng Mao, Zihua Chen, Zhikang Chen
International Journal of Cancer. 201985 CitationsOPEN ACCESS
Related on ScholarIQ
Central South University
Institution
LncRNA HOTAIR is a Prognostic Biomarker for the Proliferation and Chemoresistance of Colorectal Cancer via MiR-203a-3p-Mediated Wnt/ß-Catenin Signaling Pathway
Paper
Targeting Tumor Microenvironment by Small-Molecule Inhibitors
Paper
Overexpression of G6PD is associated with poor clinical outcome in gastric cancer
Paper
EphA2–YES1–ANXA2 pathway promotes gastric cancer progression and metastasis
Paper
EphA2‐to‐YAP pathway drives gastric cancer growth and therapy resistance
Paper